Johnson & Johnson (JNJ) Tops Q2 EPS by 9c, Beats on Revenue; Offers Strong FY25 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Johnson & Johnson (NYSE: JNJ) | Delayed: 276.32 +10.15 (3.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $266.17 | 52 Week High | $126.07 | |||
| Open | $272.41 | 52 Week Low | $94.28 | |||
| Day High | $277.35 | P/E | 57.45 | |||
| Day Low | $267.67 | EPS | $4.81 | |||
| Volume | 9,738,870 | |||||
